---
title: Are SSRIs the best treatment for PMDD? | Niyora
description: Yes, SSRIs are very effective for PMDD. All studies of fluoxetine, sertraline, paroxetine, and citalopram reported positive results, making SSRIs the emerging
url: https://niyora.com/research/papers/selective-serotonin-reuptake-inhibitors-for-premenstrual-dysphoric-disorder-the-2002/
---

- [Niyora](https://niyora.com/)
- [Research](https://niyora.com/research/)
- [Library](https://niyora.com/research/library/)
- Are SSRIs the best treatment for PMDD?

Randomised trial, 2002

# Are SSRIs the best treatment for PMDD?

Yes, SSRIs are very effective for PMDD. All studies of fluoxetine, sertraline, paroxetine, and citalopram reported positive results, making SSRIs the emerging gold standard treatment.

 Strong study design

Women with PMDD across multiple studies

## What they did

Review of 20 randomized controlled trials of SSRIs for PMDD. Twelve trials used continuous dosing throughout the cycle, while 8 trials used dosing only during the luteal phase before menses. The drugs tested included fluoxetine, sertraline, paroxetine, citalopram, and fluvoxamine.

## What they found

All treatment studies on fluoxetine, sertraline, paroxetine, and citalopram reported positive efficacy for PMDD. Most side effects were mild and transient (anxiety, dizziness, insomnia, sedation, nausea, headache). Sexual dysfunction and weight gain can be problematic long-term adverse effects, but these have not been systematically evaluated with long-term SSRI use in women with PMDD.

## What it means for you

SSRIs are well-proven and considered the gold standard for PMDD, with rapid onset of action. However, long-term side effects such as sexual dysfunction and weight gain need more systematic study. The mechanism in PMDD appears different from their use in depression.

20

Randomized controlled trials reviewed

12

Trials with continuous SSRI dosing

8

Trials with luteal phase dosing

## About the study

Original title Selective serotonin reuptake inhibitors for premenstrual dysphoric disorder: the emerging gold standard? Authors Pearlstein T Journal Drugs Year 2002 Study design Randomised trial What was tested SSRIs: fluoxetine, sertraline, paroxetine, citalopram, fluvoxamine Read the paper [doi.org/10.2165/00003495-200262130-00004](https://doi.org/10.2165/00003495-200262130-00004)

## Topics

[Premenstrual syndrome (PMS)](https://niyora.com/research/topics/condition-pms/)[Premenstrual dysphoric disorder (PMDD)](https://niyora.com/research/topics/condition-pmdd/)[Low mood and depression](https://niyora.com/research/topics/symptom-depression-mood/)[SSRIs and antidepressants](https://niyora.com/research/topics/treatment-ssri/)[Neurosteroids (allopregnanolone)](https://niyora.com/research/topics/treatment-neurosteroids/)

Research tells you what helps on average. Niyora helps on the day it hits.

Calm down, see it another way, and decide what to say, with a PMS and PMDD app built by a doctor.

## Related studies

Review, 2017

What causes PMDD and what are the best treatments?

Study, 2026

What treatments work for PMDD?

Review, 2025

What causes PMDD and why is it hard to function?

Randomised trial, 2024

Does sertraline change brain chemicals in people with PMDD, and does this relate to symptom improvement?

Randomised trial, 2022

What research topics and methods have scientists focused on when studying PMS and PMDD?

Review, 2019

Which contraceptive methods are safest for women with PMDD?

Ask AI about this page

Copy prompt

ChatGPT

↗

Claude

↗

Perplexity

↗

Google AI Mode

↗

Grok

↗